Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Prolactinoma

• Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment
• PRolaCT - Three Prolactinoma RCTs
• Dopamine D2 Receptors(D2R) Imaging in Prolactinomas
• Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma
• Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas
• Study on Therapy of Non-invasive Prolactinoma
• Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole
• Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas
• Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas.
• Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia
• Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
• Clomiphene in Males With Prolactinomas and Persistent Hypogonadism
• Cardiac Valve Complications in Prolactinomas Treated With Cabergoline